The changing landscape of relapsed and/or refractory multiple myeloma (MM): fundamentals and controversies

Overview of attention for article published in Biomarker Research, January 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#23 of 373)
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 2 news outlets

twitter: 5 X users

Citations

dimensions_citation: 18 Dimensions

Readers on

mendeley: 51 Mendeley

Summary News X Dimensions citations

So far, Dimensions has found 18 publications that cite this research output.

18

The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.

Individualized dynamic risk assessment for multiple myeloma

Preprint in medRxiv (April 2024)

Emerging Strategies to Overcome Current CAR-T Therapy Dilemmas - Exosomes Derived from CAR-T Cells

Article in International Journal of Nanomedicine (March 2024)

An overview of multiple myeloma: A monoclonal plasma cell malignancy’s diagnosis, management, and treatment modalities

Article in Saudi Journal of Biological Sciences (December 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.